Senti Biosciences is trading 5.76% up in pre-market at $0.33 versus the previous close, with no specific reason for the rise established.
- No fresh company announcement surfaced in available coverage.
- Latest filings found were dated September 24, including a prospectus and proxy materials; a September 23 filing reported a director’s resignation.
- Modest broad-index gains were not tied to the stock’s move; trading volume or activity details were not provided.